Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its revenues remained broadly unchanged year-over-year. The company also issued guidance for fiscal 2025.
Total revenues were $2.5 billion in the September quarter, compared to $2.47 billion last year. For the full year of 2025, the company expects revenues to be flat to up 1%, at constant currency, versus full year 2024.
Net income attributable to Biogen was $466.5 million or $3.17 per share in Q3, compared to $388.5 million or $2.66 per share in the third quarter of 2024. Adjusted earnings increased 18% annually to $4.81 per share in the third quarter.
The management said it expects full-year adjusted earnings per share to be in the range of $14.50 to $15.00, including expected improved business impact of approximately $0.25 EPS, offset by an expected impact in the fourth quarter from acquired IPR&D expenses.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
INTC Stock: Where does Intel stand in the semiconductor race?
Intel Corporation (NASDAQ: INTC) is working to regain dominance in the semiconductor market, while evolving from an integrated chipmaker into a global foundry player. The turnaround plan involves massive capital
J.M. Smucker (SJM) is prioritizing brands with the highest growth potential, a few points to note
Shares of The J.M. Smucker Co. (NYSE: SJM) dipped over 1% on Monday. The stock has dropped 13% over the past 12 months. The branded foods seller is operating in
Foxconn Technology reports a 22% surge in Q4 2025 revenue
Foxconn Technology Group, a key supplier for Apple Inc. (AAPL), announced financial results for the fourth quarter of fiscal 2025. Hon Hai Precision Industry Co., Foxconn's parent, said Q4 revenues increased
